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Introduction
The hippocampus plays well-established roles in perception and memory processes that are abnormal in schizophrenia [1] [2] [3] [4] . While many neuroimaging studies in the schizophrenia literature have focused on measurements of the whole hippocampus, it is anatomically heterogeneous and comprised of distinctive subfields, each with the unique functionality 5 . Subfield measurements can be more sensitive to disease processes and treatment effects than whole hippocampal measurements 6, 7 . For instance, episodic memory deficits have been reported in schizophrenia 1, 2, 8 . This abnormality has been shown to involve disruptions in separate cognitive processes such as conjunctive coding, pattern completion and pattern separation that are supported by different hippocampal subfields 9 . Conjunctive coding depends on CA3-CA3 auto-associative networks and interactions with entorhinal cortex, DG, and CA1 10 ; pattern completion mainly depends on CA3, CA1, the subiculum and their interactions 10 ; and pattern separation is supported by the DG and its interactions with CA3 11 . Because of the high-level of hippocampal neuroplasticity towards memory formation and consolidation 12 , these regions (i.e., CA1, CA3 and DG) may be more likely to be affected by pathological processes such as increased metabolic rate, neuroinflammation and oxidative stress in schizophrenia 13, 14 .
These hippocampal subfields can also be sensitive to antipsychotic treatments. The targets of antipsychotic agents, i.e., dopamine D2 receptors, have different expression across subfields, with a relatively dense expression in DG, CA3 and CA4 15, 16 ,
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suggesting that these subfields may be more likely to be affected by antipsychotic drugs. Therefore, clinical investigations of the structure can benefit from an examination of its separate subfields that include the subiculum, dentate gyrus (DG) and cornu ammonis (CA) fields comprising CA1-4 17 .
Consistent with neuropsychological findings, morphological abnormalities of the hippocampus have been associated with schizophrenia [18] [19] [20] [21] [22] . Although most studies reported local 23 or whole hippocampal volume deficits in chronic or treated firstepisode schizophrenia patients 20, 24 , there have been very few studies [25] [26] [27] conducted with antipsychotic-naïve first-episode schizophrenia patients. Thus there is no consensus on whether hippocampal atrophy or hypertrophy is present in the early stage of illness before treatment, especially at the subfield level. Of note, a recent meta-analysis reported increased right hippocampal volumes in high-risk family members of schizophrenia patients 28 . Positron emission tomography studies have shown increased metabolic rates in first-episode schizophrenia in the hippocampus compared with healthy controls 9, 29, 30 , indicating hyperactivity of the hippocampus could result in increased hippocampal volume via blood volume and neuropil changes.
Antipsychotic therapy has shown to impact hippocampus 31, 32 and antipsychotic dosage has been negatively associated with overall hippocampal volume 33 . Given the possible opposite effects on hippocampal volume by increased metabolic rates and antipsychotic treatment, data examining hippocampal subfields before and after first acute antipsychotic treatment may provide valuable information about hippocampal
abnormalities present at illness onset and effects of antipsychotic medication on this brain structure. FreeSurfer (version 6.0, http://surfer.nmr.mgh.harvard.edu/) was used to segment the hippocampal subfields ( Figure 1 ) and measure volumes in a longitudinal analysis protocol. In this framework, an unbiased within-subject template image is created using robust, inverse consistent registration across scanning time points 38 . Processing steps, including skull stripping, tissue segmentation, surface reconstruction, registration and parcellation, were initialized with common information from the within-subject template 38 . The longitudinal segmentation of hippocampal subfields tool in FreeSurfer was then applied to segment hippocampal subfields using T1
Data acquisition and hippocampal subfield segmentation
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images of the same subject at both baseline and follow-up (if available) 39 . This method uses a subject-specific atlas and treats all time points the same way to avoid processing bias, increasing the robustness of segmentation and measurement of subfield volumes 39 . The volumes of the whole hippocampus as well as twelve hippocampal subfields were extracted for each hemisphere, including the hippocampal tail, subiculum, presubiculum, parasubiculum, CA1, CA3, CA4, hippocampal fissure, granular cells layer of the dentate gyrus (GC-DG), molecular layer of the hippocampus, hippocampus-amygdala transition area (HATA) and
fimbria. All segmentation results were visually verified without knowledge of participant characteristics. Two patients were excluded from the study because of visible segmentation errors caused by poor image quality, so forty-one patients and thirty-nine healthy controls were included in statistical analyses.
Statistical analyses
Statistical analyses were performed using R software (version 3.3.3, http://www.rproject.com) and SPSS (version 24.0, U.S.A.). Differences in hippocampal subfield volumes between patients and healthy controls at baseline (before treatment for patients) were analyzed using multiple ANOVA analyses for each subfields. In these and all analyses, intracranial volume (ICV), sex and age were treated as covariates and false discovery rate (FDR) correction was applied in multiple comparisons of different subfields. All statistical tests were two-tailed.
All patients were scanned pretreatment and again at six-week follow-up, while only Table 2 ). Differences in subfield volumes in patients between baseline and follow-up were tested using a repeated measures ANOVA with the time of assessment and subfields as within-subject factors. To clarify whether hippocampal changes after antipsychotic treatment normalized the structure or increased abnormalities, we analyzed the differences in hippocampal subfield volumes between patients after treatment and healthy controls at baseline using ANOVA analyses. Correlation analysis was performed to test for associations between volume changes and symptoms changes and antipsychotic dose. In all the correlation analyses, ICV, sex and age were treated as covariates. FDR correction for multiple comparisons was also applied to correlational analysis of different subfields.
Results
Hippocampal subfield volume changes in patients before treatment
At the whole hippocampus level, there were no significant volume differences between patients and controls (SZ vs. HC, left: 3377 ± 299 mm 3 versus 3325 ± 306 mm 3 , p-value = 0.089; right: 3420 ± 290 mm 3 versus 3370 ± 340 mm 3 , p-value = 0.127). However, there were significant differences in subfield volumes between the Figure 2A ).
Hippocampal subfield volume reductions after treatment
After antipsychotic treatment, patients had significant volume reductions in the left (Table 4 ). Other regions that were significantly enlarged before treatment, i.e., bilateral ML and GC-DG, no longer showed larger volumes. No region showed significant volume increase, and no volume declines led to an abnormality in which patient volumes were significantly lower than those of healthy controls.
Changes in hippocampal volumes in relation to drug dosage and symptoms
At the whole hippocampus level, volume reduction (baselinefollow-up) in the right whole hippocampus after treatment was positively correlated with the dosage of antipsychotic medication (r = 0.56, p-value = 5.62×10 -5 ) ( Figure 3A ) 
Discussion
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In the present study, we tested for hippocampal subfield volume changes in antipsychotic-naïve first-episode schizophrenia patients before and after acute antipsychotic treatment. Before treatment, patients showed no differences in hippocampal volume globally but had significantly increased volumes in select subfields including bilateral ML, bilateral CG-DG, and bilateral CA4 compared with healthy controls. After six weeks of antipsychotic treatment, patients exhibited significant bilateral hippocampal volume decrease. While this treatment-related effect appeared to impact many subfields as shown in Table 3 and Figure 2 , it was statistically significant in bilateral hippocampal tails, left CA1, bilateral ML, bilateral GC-DG, left CA3, bilateral CA4 and left fimbria. After treatment, all enlarged subfields except bilateral CA4 were reduced to control levels, and no volume decline left any subfield volume lower than that of healthy controls. Both the pretreatment and after-treatment findings support our hypothesis that subfields fundamental to episodic memory and predominant in dopamine D2 receptor expression are affected by the illness and treatment. Also, we found positive associations between the volume reductions in multiple hippocampal subfields and dosage of antipsychotic medication.
Hippocampal subfields in antipsychotic-naïve patients before treatment
Our observations of increased hippocampal subfield volumes early in the course of illness before treatment differ from those of some prior studies. One study found no differences from controls except for a reduction in CA1 40 , and a second study reported
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a reduction in nearly all subfields except for the fimbria 41 . However, both study findings may be influenced by a somewhat longer illness duration or prior antipsychotics treatment effects, both of which have been associated with volume reductions in schizophrenia patients previous work 31, 32 . If medications or illness course are associated with reduced hippocampal subfield volumes, this reason might account for why we report increased volumes at first episode before treatment while several studies 31, 32 of chronically treated patients have reported hippocampal volume decreases. For first-episode antipsychotic-naïve studies [25] [26] [27] , especially considering subfield volumes, no consensus has yet been reached. Notably, one of our previous meta-analysis 42 found that unaffected high-risk relatives of schizophrenia patients have larger right hippocampal volume compared with healthy controls, consistent with our findings of hippocampal volume increase at illness onset.
There are several potential mechanisms which might contribute to the enlargement of certain hippocampal subfields before treatment and close to illness onset.
Neurophysiological hyperactivity of hippocampus during psychosis has been widely reported and correlated with abnormal morphology of the hippocampal formation in schizophrenia patients 41 . Considering the fairly dense dopamine D2 receptor expression and the vulnerability to excitotoxicity of DG/CA4, the increased volumes found in this study during first psychotic episodes and close to illness onset may reflect plastic modifications of hippocampus resulting from activity-dependent increases in neuropil, blood flow and myelination 9, 43 . The increased volumes in
certain subfields might also be explained by neuroinflammation 44 or abnormal reinnervation of glial cells 45 . Future studies are needed to replicate findings of the present study and determine their underlying mechanism.
Interestingly, we found a positive correlation between baseline volume of right CA3 and GAF improvement after acute treatment. Another study found that a subgroup of schizophrenia patients with bilateral hippocampal volume increase had a better outcome across clinical, functional and cognitive domains 46 . These observations suggest that volume increase in CA3 might play a compensatory or protective role in schizophrenia and can be a potential marker of good prognosis.
Hippocampal volume reduction after six weeks of antipsychotic therapy
Besides declines in total hippocampal volume bilaterally, significant subfield volume reductions after treatment were observed in all subfields with significantly increased volume before treatment (i.e., bilateral ML, GC-DG and CA4). Volume decrease was also seen in regions that did not show increased volume before treatment (bilateral hippocampal tails, left CA1, CA3, and fimbria).
While the full anatomical and functional effects of antipsychotic treatment on brain remains to be determined, prior studies have shown a decline in cortical thickness and brain volume 32, 47 , including changes in the hippocampus 31 . Acute antipsychotic effects on hippocampal subfields have also been shown in animal studies 47 . For example, olanzapine administration led to a significant volume decrease in the total
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hippocampus, CA1 and molecular layer of the DG volumes compared with vehicletreated rats 48 , which parallels our findings in schizophrenia patients. Further, using manual segmentation of hippocampal subfields, a recent longitudinal structural MRI study on first-episode patients with different psychotic disorders and limited prior treatment before and after 12 weeks of antipsychotic treatment showed significant volume reductions in the DG and CA4 after treatment 23 . Compared with controls, only bilateral CA4 still showed significantly larger volume in treated patients. Other subfields with enlarged subfields before treatment reduced volumes to control levels and no subfield showed volume loss below the level of healthy controls. In general, alterations before treatment were larger than effects of treatment (see Figure 2 ), but changes after treatment were sufficiently consistent to lead to significant treatment effects. We also found significant correlations between antipsychotic dosage and volume reductions in the right hippocampus and several of its subfields. The observed lateralization in correlation analysis might reflect differences of neuroplasticity resulting from antipsychotics between the left and right hippocampus 49 . While the right lateralization is consistent with the lateralized finding in the meta-analysis of unaffected relatives, confirmation of the laterality effect is needed as well as understanding of its molecular mechanism.
The significantly dose-related hippocampal volume changes in patients after treatment who were typically ill for months and showed robust clinical improvement after treatment, are consistent with the interpretation that the changes observed after
antipsychotic treatment are pharmacological effects. There are several possibilities that might explain these findings. One hypothesis is that antipsychotic treatment may have alleviated the pathophysiological processes related to illness onset, resulting in a normalizing reduction in abnormal regional volumes evident before treatment.
However, it is also possible that the volume reduction represents an adverse effect of 
Conclusion
Before treatment, larger volumes of hippocampal subfields were observed in the antipsychotic-naïve schizophrenia patients than healthy controls in bilateral CA4, GC- [Color, 2-colum]
Figure 3: Association between hippocampal volume reduction and antipsychotic dosage in schizophrenia patients.
A: Positive correlation of the volume reduction in the right hippocampus with the
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antipsychotic dosage in CPZ equivalents. B-H: Positive correlation of the volume reductions in the left CA1, the right CA1, the right ML, the right GC-DG, the right CA4, and the right HATA with the antipsychotic dosage in CPZ equivalents.
Abbreviations: CA, cornu ammonis; GC-DG, granular cells layer of the dentate gyrus;
HATA, hippocampus-amygdala transition area; ML, molecular layers.
[Black & White, 2-colum]
A C C E P T E D M A N U S C R I P T Abbreviations: PANSS, positive and negative syndrome scale; SD, standard deviation; SZ, schizophrenia patients;
HC, healthy controls.
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Highlights  Specific hippocampal subfields were enlarged in patients before treatment.
 Volume decrease in regions with dense D2 receptors (CA3-4 and DG) after treatment.
 Most enlarged subfields pretreatment were reduced to normal level after treatment.
 Dosage of antipsychotics was associated with the degree of volume reduction. 
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